404 related articles for article (PubMed ID: 20648554)
1. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.
Chen W; Chang B; Li L; Chan L
Hepatology; 2010 Sep; 52(3):1134-42. PubMed ID: 20648554
[TBL] [Abstract][Full Text] [Related]
2. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.
Basantani MK; Sitnick MT; Cai L; Brenner DS; Gardner NP; Li JZ; Schoiswohl G; Yang K; Kumari M; Gross RW; Zechner R; Kershaw EE
J Lipid Res; 2011 Feb; 52(2):318-29. PubMed ID: 21068004
[TBL] [Abstract][Full Text] [Related]
3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
4. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats.
Kumashiro N; Yoshimura T; Cantley JL; Majumdar SK; Guebre-Egziabher F; Kursawe R; Vatner DF; Fat I; Kahn M; Erion DM; Zhang XM; Zhang D; Manchem VP; Bhanot S; Gerhard GS; Petersen KF; Cline GW; Samuel VT; Shulman GI
Hepatology; 2013 May; 57(5):1763-72. PubMed ID: 23175050
[TBL] [Abstract][Full Text] [Related]
5. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.
Santoro N; Kursawe R; D'Adamo E; Dykas DJ; Zhang CK; Bale AE; Calí AM; Narayan D; Shaw MM; Pierpont B; Savoye M; Lartaud D; Eldrich S; Cushman SW; Zhao H; Shulman GI; Caprio S
Hepatology; 2010 Oct; 52(4):1281-90. PubMed ID: 20803499
[TBL] [Abstract][Full Text] [Related]
6. Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.
Hao L; Ito K; Huang KH; Sae-tan S; Lambert JD; Ross AC
Metabolism; 2014 Oct; 63(10):1352-62. PubMed ID: 25060692
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.
Wang Y; Kory N; BasuRay S; Cohen JC; Hobbs HH
Hepatology; 2019 Jun; 69(6):2427-2441. PubMed ID: 30802989
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans.
Sevastianova K; Kotronen A; Gastaldelli A; Perttilä J; Hakkarainen A; Lundbom J; Suojanen L; Orho-Melander M; Lundbom N; Ferrannini E; Rissanen A; Olkkonen VM; Yki-Järvinen H
Am J Clin Nutr; 2011 Jul; 94(1):104-11. PubMed ID: 21525193
[TBL] [Abstract][Full Text] [Related]
9. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes.
Dubuquoy C; Robichon C; Lasnier F; Langlois C; Dugail I; Foufelle F; Girard J; Burnol AF; Postic C; Moldes M
J Hepatol; 2011 Jul; 55(1):145-53. PubMed ID: 21145868
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis.
BasuRay S; Wang Y; Smagris E; Cohen JC; Hobbs HH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9521-9526. PubMed ID: 31019090
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
12. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status.
Hoekstra M; Li Z; Kruijt JK; Van Eck M; Van Berkel TJ; Kuiper J
J Hepatol; 2010 Feb; 52(2):244-51. PubMed ID: 20015565
[TBL] [Abstract][Full Text] [Related]
13. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.
Smagris E; BasuRay S; Li J; Huang Y; Lai KM; Gromada J; Cohen JC; Hobbs HH
Hepatology; 2015 Jan; 61(1):108-18. PubMed ID: 24917523
[TBL] [Abstract][Full Text] [Related]
14. Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets.
Mitsche MA; Hobbs HH; Cohen JC
J Biol Chem; 2018 May; 293(18):6958-6968. PubMed ID: 29555681
[TBL] [Abstract][Full Text] [Related]
15. Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression.
Wieser V; Adolph TE; Enrich B; Moser P; Moschen AR; Tilg H
Liver Int; 2017 Feb; 37(2):299-306. PubMed ID: 27514759
[TBL] [Abstract][Full Text] [Related]
16. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein.
Romeo S; Huang-Doran I; Baroni MG; Kotronen A
Curr Opin Lipidol; 2010 Jun; 21(3):247-52. PubMed ID: 20480550
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
Matsuzaka T; Kuba M; Koyasu S; Yamamoto Y; Motomura K; Arulmozhiraja S; Ohno H; Sharma R; Shimura T; Okajima Y; Han SI; Aita Y; Mizunoe Y; Osaki Y; Iwasaki H; Yatoh S; Suzuki H; Sone H; Takeuchi Y; Yahagi N; Miyamoto T; Sekiya M; Nakagawa Y; Ema M; Takahashi S; Tokiwa H; Shimano H
Hepatology; 2020 May; 71(5):1609-1625. PubMed ID: 31529722
[TBL] [Abstract][Full Text] [Related]
18. Isoleucine-to-methionine substitution at residue 148 variant of PNPLA3 gene and metabolic outcomes in gestational diabetes.
Bo S; Gambino R; Menato G; Canil S; Ponzo V; Pinach S; Durazzo M; Ghigo E; Cassader M; Musso G
Am J Clin Nutr; 2015 Feb; 101(2):310-8. PubMed ID: 25646328
[TBL] [Abstract][Full Text] [Related]
19. Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice.
Tsai HP; Hou PH; Mao FC; Chang CC; Yang WC; Wu CF; Liao HJ; Lin TC; Chou LS; Hsiao LW; Chang GR
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401717
[TBL] [Abstract][Full Text] [Related]
20. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
Lindén D; Ahnmark A; Pingitore P; Ciociola E; Ahlstedt I; Andréasson AC; Sasidharan K; Madeyski-Bengtson K; Zurek M; Mancina RM; Lindblom A; Bjursell M; Böttcher G; Ståhlman M; Bohlooly-Y M; Haynes WG; Carlsson B; Graham M; Lee R; Murray S; Valenti L; Bhanot S; Åkerblad P; Romeo S
Mol Metab; 2019 Apr; 22():49-61. PubMed ID: 30772256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
